Wang C, Lin Y, Zhou Y, Mao F, et al. Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for
HER2 positive and hormone receptor positive metastatic or locally advanced breast
cancer: study protocol of a randomized controlled trial. BMC Cancer 2020;20:653.
PMID: 32660609